Timeline

Yu Wei
Group Leader
16 May 2024
publication

CALCOCO2/NDP52 associates with RAB9 to initiate an antiviral response to hepatitis B virus infection through a lysosomal degradation pathway.

Read more
19 Dec 2023
publication

NDP52 mediates an antiviral response to hepatitis B virus infection through Rab9-dependent lysosomal degradation pathway.

Read more
21 Dec 2022
publication

Full-Lung Prophylaxis against SARS-CoV-2 by One-Shot or Booster Intranasal Lentiviral Vaccination in Syrian Golden Hamsters

Read more
28 Sep 2016
publication

Single-nucleotide-resolution mapping of HBV promoters in infected human livers and hepatocellular carcinoma

Read more
05 Nov 2015
publication

Deficiency of multidrug resistance 2 contributes to cell transformation through oxidative stress

Read more
06 Jul 2015
project

Molecular mechanisms regulating hepatitis B virus replication and liver carcinogenesis

Read more
01 Aug 2013
publication

LIM-only protein FHL2 activates NF-κB signaling in the control of liver regeneration and hepatocarcinogenesis.

Read more
28 Feb 2013
publication

The LIM-only protein FHL2 controls mesenchymal cell osteogenic differentiation and bone formation through Wnt5a and Wnt10b

Read more
15 Jan 2013
publication

The four and a half LIM-only protein 2 (FHL2) activates transforming growth factor β (TGF-β) signaling by regulating ubiquitination of the E3 ligase Arkadia

Read more
11 Jul 2012
publication

The four and a half LIM-only protein 2 regulates liver homeostasis and contributes to carcinogenesis

Read more
18 May 2010
publication

Molecular biology of the hepatitis B virus and role of the X gene

Read more
28 Apr 2010
publication

Deficiency of the LIM-only protein FHL2 reduces intestinal tumorigenesis in Apc mutant mice

Read more
01 Dec 2008
publication

Hepatic stem-like phenotype and interplay of Wnt/beta-catenin and Myc signaling in aggressive childhood liver cancer

Read more
19 Nov 2008
publication

The LIM-only protein FHL2 mediates ras-induced transformation through cyclin D1 and p53 pathways

Read more
31 Mar 2008
publication

The LIM-only protein FHL2 regulates cyclin D1 expression and cell proliferation

Read more
01 Feb 2007
publication

Tbx3 is a downstream target of the Wnt/beta-catenin pathway and a critical mediator of beta-catenin survival functions in liver cancer

Read more
01 May 2006
publication

The LIM-only protein FHL2 is a negative regulator of E4F1

Read more
13 Feb 2003
publication

Identification of the LIM protein FHL2 as a coactivator of beta-catenin

Read more
01 Sep 2002
publication

Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features

Read more
01 Jun 2002
publication

Genetic alterations and oncogenic pathways in hepatocellular carcinoma

Read more
27 Jan 2000
publication

Activation of beta-catenin in epithelial and mesenchymal hepatoblastomas

Read more
01 Sep 1999
publication

Nuclear accumulation of mutated beta-catenin in hepatocellular carcinoma is associated with increased cell proliferation

Read more